The White House called for further review from the scientific community on human genome editing in a note issued Tuesday.» Read More
Many customers shopping for Obamacare's most popular plans will see only modest increases—or even price cuts—on many of the cheapest plans.
To fast-track autism research, Google and scientists are using data analytics to find its roots and possible cures.
Weeks after Facebook's CEO gave $25 million to fight Ebola in Africa, his company is rolling out three initiatives to raise awareness and more money.
The U.S. FDA has revoked a tentative approval for India's Ranbaxy to make a cheap copy of AstraZeneca's heartburn drug Nexium.
Pascal Soriot, chief executive of AstraZeneca, said the U.S. had nearly removed the effect of tax inversion deals like Pfizer's bid for his company.
The federal government wants large employers' insurance offerings to cover hospitalizations if they are to avoid Obamacare fines.
Want to know what's giving health stocks confidence in profit forecasts? Like it or not, it's the Affordable Care Act, aka Obamacare.
The Obama administration urged governors who haven't expanded their Medicaid programs to join 27 other states and Washington, D.C., in doing so.
A start-up has created technology it says can detect a variety of cancers with a device that can be used in a GP's surgery – or even at home.
Working irregular shifts could be damaging an individual’s everyday life, internal body clock and social life.
Eleven states that aren't running Obamacare exchanges still want financial aid for residents who bought insurance on HealthCare.gov.
There is real investment opportunity right now in health care, says the head of Google's venture capital investment arm.
The U.S. Supreme Court isn't taking up a huge threat to Obamacare. Yet.
Here are four things we learned from the CDC's handling of Ebola, says consultant Ron Carucci.
A new survey finds just 43 percent of people who tried out Obamacare health insurance exchanges in the last year plan on returning this year.
A woman in London has been tested clear of Ebola after showing "haemorraghic fever" symptoms, health officials have said.
Laboratory Corp. of America said it would buy contract research company Covance for about $6.1 billion in cash and stock.
Whether recent price changes in individual insurance plans are a good or a bad thing depends on your perspective.
The fight over Ebola quarantines in the U.S. is discouraging doctors, nurses and other health workers from going to Africa. NBC News reports.
With the midterm elections Tuesday, businesses in select states have much at stake with ballot outcomes that could impact marijuana use, minimum wages and Medicaid.
Get the best of CNBC in your inbox